Cooper Companies (COO)

Create an Alert
120.80 -0.89  -0.73%   NYSE Jun 19, 5:00PM BATS Real time Currency in USD

Cooper Companies R&D Expense Quarterly:

14.49M for April 30, 2013
View Full Chart

Cooper Companies R&D Expense Quarterly Chart

    Cooper Companies Historical R&D Expense Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 2   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    April 30, 2013 14.49M
    Jan. 31, 2013 13.65M
    Oct. 31, 2012 14.12M
    July 31, 2012 13.16M
    April 30, 2012 13.03M
    Jan. 31, 2012 11.42M
    Oct. 31, 2011 11.74M
    July 31, 2011 11.72M
    April 30, 2011 10.39M
    Jan. 31, 2011 9.727M
    Oct. 31, 2010 10.49M
    July 31, 2010 8.588M
    April 30, 2010 8.573M
    Jan. 31, 2010 7.626M
    Oct. 31, 2009 8.266M
    July 31, 2009 7.737M
    April 30, 2009 10.06M
    Jan. 31, 2009 7.232M
    Oct. 31, 2008 9.19M
    July 31, 2008 9.03M
    April 30, 2008 Go Pro
    Jan. 31, 2008 Go Pro
    Oct. 31, 2007 Go Pro
    July 31, 2007 Go Pro
    April 30, 2007 Go Pro
       
    Jan. 31, 2007 Go Pro
    Oct. 31, 2006 Go Pro
    July 31, 2006 Go Pro
    April 30, 2006 Go Pro
    Jan. 31, 2006 Go Pro
    Oct. 31, 2005 Go Pro
    July 31, 2005 Go Pro
    April 30, 2005 Go Pro
    Jan. 31, 2005 Go Pro
    Oct. 31, 2004 Go Pro
    July 31, 2004 Go Pro
    April 30, 2004 Go Pro
    Jan. 31, 2004 Go Pro
    Oct. 31, 2003 Go Pro
    July 31, 2003 Go Pro
    April 30, 2003 Go Pro
    Jan. 31, 2003 Go Pro
    Oct. 31, 2002 Go Pro
    July 31, 2002 Go Pro
    April 30, 2002 Go Pro
    Jan. 31, 2002 Go Pro
    Oct. 31, 2001 Go Pro
    July 31, 2001 Go Pro
    April 30, 2001 Go Pro
    Jan. 31, 2001 Go Pro

    About R&D Expense

    R&D expenses are a line item from many companies' income statements.

    R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

    Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

    An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
    Learn More

    Get data for

    COO R&D Expense Quarterly Benchmarks

    Companies
    Becton Dickinson 122.38M
    Conmed Corporation 5.694M
    West Pharmaceutical Services 9.10M

    COO R&D Expense Quarterly Rankings

    Overall 96th percentile
    654 of 16782
    Sector 88th percentile
    164 of 1410 in Healthcare
    Industry 86th percentile
    21 of 152 in Medical Instruments & Supplies

    COO R&D Expense Quarterly Range, Past 5 Years

    Minimum 7.232M Jan 2009
    Maximum 14.49M Apr 2013
    Average 10.51M

    Access watchlists and custom data alerts.
    Start your free account.

    Registering enables you to view unlimited pages per month.

    required
    required
    required
    required
    Get Started Now

    Already registered? Sign in here.

    document.write('');